- Home
- EPAC vs BEAM Comparison
EPAC vs BEAM Comparison
Compare EPAC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- BEAM
- Stock Information
- Founded
- EPAC 1910
- BEAM 2017
- Country
- EPAC United States
- BEAM United States
- Employees
- EPAC N/A
- BEAM N/A
- Industry
- EPAC Industrial Machinery/Components
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPAC Technology
- BEAM Health Care
- Exchange
- EPAC Nasdaq
- BEAM Nasdaq
- Market Cap
- EPAC 2.3B
- BEAM 1.9B
- IPO Year
- EPAC N/A
- BEAM 2020
- Fundamental
- Price
- EPAC $45.34
- BEAM $25.75
- Analyst Decision
- EPAC
- BEAM Buy
- Analyst Count
- EPAC 0
- BEAM 10
- Target Price
- EPAC N/A
- BEAM $48.75
- AVG Volume (30 Days)
- EPAC 317.3K
- BEAM 1.1M
- Earning Date
- EPAC 03-19-2025
- BEAM 02-25-2025
- Dividend Yield
- EPAC 0.09%
- BEAM N/A
- EPS Growth
- EPAC 63.65
- BEAM N/A
- EPS
- EPAC 1.65
- BEAM N/A
- Revenue
- EPAC $592,736,000.00
- BEAM $349,643,000.00
- Revenue This Year
- EPAC $7.71
- BEAM N/A
- Revenue Next Year
- EPAC $7.87
- BEAM $14.08
- P/E Ratio
- EPAC $27.51
- BEAM N/A
- Revenue Growth
- EPAC N/A
- BEAM 328.73
- 52 Week Low
- EPAC $30.43
- BEAM $20.84
- 52 Week High
- EPAC $51.91
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- EPAC 59.37
- BEAM 49.43
- Support Level
- EPAC $44.32
- BEAM $24.33
- Resistance Level
- EPAC $45.72
- BEAM $27.97
- Average True Range (ATR)
- EPAC 0.93
- BEAM 1.55
- MACD
- EPAC 0.34
- BEAM 0.13
- Stochastic Oscillator
- EPAC 86.68
- BEAM 59.41
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.